CompoSecure [CMPOW] vs Proto Labs [PRLB] Detailed Stock Comparison
CompoSecure
NASDAQ
Loading...
Proto Labs
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: CompoSecure wins in 11 metrics, Proto Labs wins in 4 metrics, with 0 ties. CompoSecure appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | CompoSecure | Proto Labs | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 77.70 | N/A |
| Price-to-Book Ratio | N/A | 1.67 | N/A |
| Debt-to-Equity Ratio | 0.00 | 0.43 | CompoSecure |
| PEG Ratio | N/A | 31.71 | N/A |
| EV/EBITDA | 8.95 | 17.58 | CompoSecure |
| Profit Margin (TTM) | -28.15% | 2.91% | Proto Labs |
| Operating Margin (TTM) | 17.95% | 3.79% | CompoSecure |
| EBITDA Margin (TTM) | 17.95% | 3.79% | CompoSecure |
| Return on Equity | 37.45% | 2.19% | CompoSecure |
| Return on Assets (TTM) | 11.33% | 1.86% | CompoSecure |
| Free Cash Flow (TTM) | $121.11M | $68.66M | CompoSecure |
| 1-Year Return | 481.60% | 64.62% | CompoSecure |
| Price-to-Sales Ratio (TTM) | 2.26 | 2.19 | Proto Labs |
| Enterprise Value | $1.08B | $1.01B | CompoSecure |
| EV/Revenue Ratio | 2.56 | 1.99 | Proto Labs |
| Gross Profit Margin (TTM) | 48.06% | 44.26% | CompoSecure |
| Revenue per Share (TTM) | $3 | $21 | Proto Labs |
| Earnings per Share (Diluted) | N/A | $0.60 | N/A |
| Beta (Stock Volatility) | 0.97 | 1.33 | CompoSecure |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
CompoSecure vs Proto Labs Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| CompoSecure | 46.07% | 57.74% | 45.62% | 120.47% | 118.94% | 103.87% |
| Proto Labs | 0.71% | 7.94% | 14.52% | 15.97% | 10.29% | 20.31% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| CompoSecure | 481.60% | 1,042.17% | 148.17% | 53.40% | 28.28% | 28.28% |
| Proto Labs | 64.62% | 0.41% | -64.70% | -37.37% | 60.76% | 60.76% |
Performance & Financial Health Analysis: CompoSecure vs Proto Labs
| Metric | CMPOW | PRLB |
|---|---|---|
| Market Information | ||
| Market Cap | $952.39M | $1.11B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 43,726 | 241,390 |
| 90 Day Avg. Volume | 34,127 | 196,843 |
| Last Close | $9.48 | $46.62 |
| 52 Week Range | $3.79 - $9.51 | $26.35 - $48.00 |
| % from 52W High | -0.32% | -2.88% |
| All-Time High | $14.51 (Jan 08, 2018) | $286.57 (Jan 25, 2021) |
| % from All-Time High | -34.67% | -83.73% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.41% | 0.08% |
| Quarterly Earnings Growth | -0.42% | -0.03% |
| Financial Health | ||
| Profit Margin (TTM) | -0.28% | 0.03% |
| Operating Margin (TTM) | 0.18% | 0.04% |
| Return on Equity (TTM) | 0.37% | 0.02% |
| Debt to Equity (MRQ) | 0.00 | 0.43 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-1.04 | $27.84 |
| Cash per Share (MRQ) | $0.05 | $4.32 |
| Operating Cash Flow (TTM) | $66.60M | $71.01M |
| Levered Free Cash Flow (TTM) | $159.49M | $64.86M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: CompoSecure vs Proto Labs
| Metric | CMPOW | PRLB |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 77.70 |
| Forward P/E | N/A | 31.71 |
| PEG Ratio | N/A | 31.71 |
| Price to Sales (TTM) | 2.26 | 2.19 |
| Price to Book (MRQ) | N/A | 1.67 |
| Market Capitalization | ||
| Market Capitalization | $952.39M | $1.11B |
| Enterprise Value | $1.08B | $1.01B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.56 | 1.99 |
| Enterprise to EBITDA | 8.95 | 17.58 |
| Risk & Other Metrics | ||
| Beta | 0.97 | 1.33 |
| Book Value per Share (MRQ) | $-1.04 | $27.84 |
Financial Statements Comparison: CompoSecure vs Proto Labs
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | CMPOW | PRLB |
|---|---|---|
| Revenue/Sales | $59.82M | $135.06M |
| Cost of Goods Sold | $31.08M | $75.29M |
| Gross Profit | $28.75M | $59.77M |
| Research & Development | N/A | $11.17M |
| Operating Income (EBIT) | $6.04M | $5.12M |
| EBITDA | $7.81M | $13.84M |
| Pre-Tax Income | $33.65M | $6.67M |
| Income Tax | $27.00M | $2.25M |
| Net Income (Profit) | $21.49M | $4.43M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | CMPOW | PRLB |
|---|---|---|
| Cash & Equivalents | $9.51M | $82.69M |
| Total Current Assets | $10.83M | $194.41M |
| Total Current Liabilities | $47.09M | $62.09M |
| Long-Term Debt | $0 | $1.70M |
| Total Shareholders Equity | $-87.31M | $656.80M |
| Retained Earnings | $-293.59M | $236.55M |
| Property, Plant & Equipment | $0 | $224.29M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | CMPOW | PRLB |
|---|---|---|
| Operating Cash Flow | $9.71M | $11.14M |
| Capital Expenditures | $0 | $-1.26M |
| Free Cash Flow | $2.62M | $17.12M |
| Debt Repayment | $0 | $-76,000 |
| Common Stock Repurchase | N/A | $-22.14M |
Short Interest & Institutional Ownership Analysis
| Metric | CMPOW | PRLB |
|---|---|---|
| Shares Short | N/A | 656,829 |
| Short Ratio | N/A | 3.78 |
| Short % of Float | N/A | 0.04% |
| Average Daily Volume (10 Day) | 43,726 | 241,390 |
| Average Daily Volume (90 Day) | 34,127 | 196,843 |
| Shares Outstanding | 100.46M | 24.23M |
| Float Shares | 36.10M | 23.60M |
| % Held by Insiders | N/A | 0.01% |
| % Held by Institutions | N/A | 0.94% |
Dividend Analysis & Yield Comparison: CompoSecure vs Proto Labs
| Metric | CMPOW | PRLB |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |